Search Within

Jorge Gomez

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Advanced Practice Providers (7)
  2. Department of Medicine (7)
  3. Nursing (7)
  4. Solid Tumor Oncology Division (7)
  5. Survivorship Research (7)
  6. Thoracic Oncology (7)

More Groups

People
  1. Christopher Azzoli (7)
  2. Mark Kris (7)
  3. Megan Dunne (7)
  4. Lee Krug (6)
  5. Vincent Miller (6)
  6. Barbara Pizzo (5)

More People

Years
  1. 2007 (1)
  2. 2006 (1)
  3. 2005 (2)
  4. 2004 (2)
  5. 2003 (1)
Publications
  1. Cancer (2)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. Lung Cancer (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Wiley Blackwell (2)
  4. Elsevier Ireland Ltd. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
    Journal Article

    Milton, D. T.; Azzoli, C. G.; Heelan, R. T.; Venkatraman, E.; Gomez, J. E.; Kris, M. G.; Krug, L. M.; Pao, W.; Rizvi, N. A.; Dunne, M.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX, pralatrexate) plus docetaxel in patients with advanced Non-Small Cell Lung Cancer (NSCLC)
    Meeting Abstract

    Gomez, J.; Azzoli, C.; Krug, L.; Ginsberg, M.; Henry, R.; Tyson, L.; Pizzo, B.; Dunne, M.; Kris, M.; Sirotnak, F.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial
    Journal Article

    Krug, L. M.; Crapanzano, J. P.; Azzoli, C. G.; Miller, V. A.; Rizvi, N.; Gomez, J.; Kris, M. G.; Pizzo, B.; Tyson, L.; Dunne, M.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study
    Meeting Abstract

    Milton, D. T.; Miller, V. A.; Azzoli, C. G.; Dunne, M.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Ramies, D.; Rizvi, N. A.; Kris, M. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial
    Meeting Abstract

    Krug, L. M.; Crapanzano, J. P.; Miller, V. A.; Azzoli, C. G.; Rizvi, N.; Gomez, J.; Pizzo, B.; Tyson, L.; Dunne, M.; Kris, M. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer
    Meeting Abstract

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Sharma, S.; Gomez, J.; Kris, M. G.; Ginsberg, M.; Baez, V.; Henry, R.; Tyson, L.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save